Jeffrey B. Sprecher

Jeffrey B. Sprecher serves as a procurement professional responsible for managing complex acquisitions in advanced manufacturing and scientific instrumentation sectors. His role centers on ensuring the timely and compliant delivery of specialized equipment critical to national research, healthcare, and technical infrastructure missions. He oversees the full lifecycle of contract actions—from market research and solicitation to award and administration—focusing on high-precision analytical and medical devices that require stringent technical validation and regulatory alignment. His work supports mission-critical capabilities through strategic sourcing aligned with federal acquisition regulations. Sprecher maintains a broad network of vendors spanning large-scale manufacturers and niche suppliers, with no single contractor dominating his portfolio. His contracting patterns reflect a balanced approach, engaging both established industrial firms and specialized innovators capable of meeting exacting performance standards. He prioritizes vendor reliability, technical capability, and past performance over volume, fostering long-term partnerships with firms demonstrating consistent quality and compliance in regulated environments. His procurement strategy emphasizes non-set-aside acquisitions, with 88.1% of awards issued under full and open competition, reflecting a preference for technical merit over socioeconomic categorization. However, he consistently allocates 11.9% of opportunities to total small business set-asides under FAR 19.5, demonstrating a measured commitment to small business participation without compromising mission requirements. His approach aligns with agency objectives to maintain a robust supplier base while ensuring access to cutting-edge capabilities. Sprecher’s primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing), where he acquires mass spectrometers, chromatography systems, and precision measurement tools. He also regularly procures electromedical devices (334510) and surgical supplies (339113), indicating deep expertise in biomedical and laboratory technology domains. His technical acumen spans regulatory frameworks including FDA 21 CFR Part 820 and ISO 13485, positioning him as a specialist in high-compliance, low-volume, high-precision acquisitions.